Occurrence of CYP2B6 516G>T polymorphism in patients with ARV‐associated hepatotoxicity

BACKGROUND: Hepatic enzyme cytochrome P450 2B6 (CYP2B6) plays a role in the metabolism of efavirenz drugs. CYP2B6 516G>T variation showed an implication for HIV treatment. METHODS: CYP2B6 516G>T polymorphism was genotyped in a total 165 HIV patients that include 34 with and 131 without hepatot...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, HariOm, Lata, Sonam, Dhole, T. N., Gangakhedkar, Raman R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465650/
https://www.ncbi.nlm.nih.gov/pubmed/30864294
http://dx.doi.org/10.1002/mgg3.598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465650/
https://www.ncbi.nlm.nih.gov/pubmed/30864294
http://dx.doi.org/10.1002/mgg3.598

Ejemplares similares